- Presentations
- 3
- Markets
- 1
Spevigo is a brand of Spesolimab marketed by Boehringer Ingelheim Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Spesolimab
- Brand owner
- Boehringer Ingelheim Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 150 mg injection, 300 mg injection, 450 mg/7.5 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Spevigo 150 mg injectionIntravenous Cold chain | Boehringer Ingelheim Pharmaceuticals | US FDA | Available on request |
| Spevigo 300 mg injectionIntravenous Cold chain | Boehringer Ingelheim Pharmaceuticals | US FDA | Available on request |
| Spevigo 450 mg/7.5 mL injectionIntravenous Cold chain | Boehringer Ingelheim Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Spesolimab.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Spevigo
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.